Fingolimod Withdrawn Phase 3 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01941004Safety and Efficacy of Fingolimod in MS Patients in China